KLYG (Kelyniam Global) Tax Expense: $0.00 Mil (TTM As of Mar. 2008)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Kelyniam Global Tax Expense?

Kelyniam Global KLYG -16.00% Tax Expense is $0.00 Mil as of Mar. 2008.

Kelyniam Global's tax expense for the months ended in Mar. 2008 was $0.00 Mil. Its tax expense for the trailing twelve months (TTM) ended in Mar. 2008 was $0.00 Mil.

Kelyniam Global  (OTCPK:KLYG) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.

Kelyniam Global Tax Expense Related Terms

Kelyniam Global Tax Expense Historical Data

* Premium members only.

The historical data trend for Kelyniam Global's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kelyniam Global Tax Expense Chart

Kelyniam Global Annual Data
Trend Dec06 Dec07
Tax Expense
0.00 0.00

Kelyniam Global Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08
Tax Expense Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Kelyniam Global Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Mar. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Expense →
What does a Tax Expense of $0.00 Mil mean?
Kelyniam Global (KLYG) has a Tax Expense of $0.00 Mil as of Mar. 2008. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Kelyniam Global and its competitors.
Is Kelyniam Global's Tax Expense too high?
Kelyniam Global's current Tax Expense is $0.00 Mil.
How does Kelyniam Global's Tax Expense compare to VASO and WCUI?
Kelyniam Global's Tax Expense of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Expense for a Medical Devices & Instruments company?
A good Tax Expense depends on the Medical Devices & Instruments industry context. However, Tax Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Expense mean?
A high Tax Expense can signal that a stock is expensive relative to its fundamentals. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Kelyniam Global and its competitors. Kelyniam Global's current Tax Expense is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kelyniam Global stock overvalued right now?
Kelyniam Global (KLYG) has a current Tax Expense of $0.00 Mil. The current Tax Expense is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Expense calculated?
Tax Expense is calculated from a company's financial statements. For Kelyniam Global (KLYG), the current Tax Expense is $0.00 Mil as of Mar. 2008. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kelyniam Global Business Description

Address 97 River Road, Suite A, Canton, CT, USA, 06019
Kelyniam Global Inc specializes in the rapid production of custom prosthetic cranial implants utilizing computer-aided design and computer aided manufacturing of developed medical grade polymers. The Company develops, manufactures, and distributes custom cranial and maxilla-facial implants for patients requiring the reconstruction of cranial and certain facial structures. The Company's business operations consist of regulatory approvals, manufacturing operations and distribution to customers and markets in the United States.